CINECA IRIS Institutional Research Information System

TURCHETTI, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.958
AS - Asia 1.347
EU - Europa 1.060
SA - Sud America 201
AF - Africa 127
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 4.697
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.899
SG - Singapore 440
CN - Cina 295
IT - Italia 264
HK - Hong Kong 182
BR - Brasile 174
SE - Svezia 162
DE - Germania 151
VN - Vietnam 148
GB - Regno Unito 101
IN - India 85
FR - Francia 76
FI - Finlandia 68
BG - Bulgaria 54
CI - Costa d'Avorio 52
JP - Giappone 43
CA - Canada 39
NL - Olanda 37
TR - Turchia 37
AT - Austria 29
RU - Federazione Russa 25
SN - Senegal 23
ID - Indonesia 20
BD - Bangladesh 17
NG - Nigeria 17
PL - Polonia 16
UA - Ucraina 16
KR - Corea 15
ZA - Sudafrica 15
ES - Italia 13
AR - Argentina 11
PK - Pakistan 10
IQ - Iraq 9
MX - Messico 9
SA - Arabia Saudita 8
AZ - Azerbaigian 7
PT - Portogallo 7
BE - Belgio 6
CH - Svizzera 6
CZ - Repubblica Ceca 6
MA - Marocco 5
CL - Cile 4
EG - Egitto 4
IR - Iran 4
LT - Lituania 4
LV - Lettonia 4
PH - Filippine 4
TT - Trinidad e Tobago 4
VE - Venezuela 4
CR - Costa Rica 3
DZ - Algeria 3
JO - Giordania 3
KE - Kenya 3
KZ - Kazakistan 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AU - Australia 2
CO - Colombia 2
GE - Georgia 2
HR - Croazia 2
IL - Israele 2
MY - Malesia 2
PA - Panama 2
PE - Perù 2
RO - Romania 2
RS - Serbia 2
TN - Tunisia 2
UZ - Uzbekistan 2
XK - ???statistics.table.value.countryCode.XK??? 2
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BJ - Benin 1
EC - Ecuador 1
EE - Estonia 1
ET - Etiopia 1
GH - Ghana 1
GR - Grecia 1
GT - Guatemala 1
HU - Ungheria 1
IE - Irlanda 1
MD - Moldavia 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
NI - Nicaragua 1
PS - Palestinian Territory 1
PY - Paraguay 1
SI - Slovenia 1
SR - Suriname 1
UY - Uruguay 1
Totale 4.697
Salva come PNG Salva come JPEG
Città #
Ashburn 287
Singapore 253
Dallas 234
Hong Kong 180
San Jose 155
Santa Clara 137
Chandler 125
Ann Arbor 82
Shanghai 75
Munich 64
Fairfield 58
Beijing 55
Serra 55
Ho Chi Minh City 54
Sofia 54
New York 53
Abidjan 52
Los Angeles 52
Florence 43
London 41
Boardman 38
Houston 38
Turku 36
Tokyo 34
Hanoi 33
Princeton 30
Wilmington 30
Seattle 29
Pisa 27
Woodbridge 27
Vienna 26
Lauterbourg 24
Dakar 23
Frankfurt am Main 23
Lawrence 23
Helsinki 22
Bremen 19
Hyderabad 18
Medford 18
Hefei 17
Lagos 17
Istanbul 16
Lancaster 16
Redwood City 15
Buffalo 14
Milan 14
Warsaw 14
Düsseldorf 13
Izmir 13
Ottawa 13
Redondo Beach 13
Rome 13
Seoul 13
Jacksonville 12
São Paulo 12
Fuzhou 11
Jakarta 11
Ogden 11
Cambridge 10
Chennai 10
Johannesburg 10
Kent 10
San Diego 9
Belo Horizonte 8
Haiphong 8
Rio de Janeiro 8
Baku 7
Council Bluffs 7
Dearborn 7
Mumbai 7
Nanjing 7
Orem 7
Phoenix 7
Amsterdam 6
Brussels 6
Chicago 6
Livorno 6
Madrid 6
Manchester 6
Marseille 6
Montreal 6
Toronto 6
Washington 6
Bengaluru 5
Curitiba 5
Denver 5
Des Moines 5
Duncan 5
Goiânia 5
Hải Dương 5
Poplar 5
Portsmouth 5
Stockholm 5
Torres Vedras 5
Vancouver 5
Bari 4
Boulder 4
Brasília 4
Cascina 4
Columbus 4
Totale 3.147
Salva come PNG Salva come JPEG
Nome #
Diagnosis and referral of rheumatoid arthritis by primary care physician: results of a pilot study on the city of Pisa, Italy 184
Minimally invasive distal pancreatectomy: a case-matched cost-analysis between robot-assisted surgery and direct manual laparoscopy 180
Direct health care costs among patients with rheumatoid arthritis before and after the initiation of treatment with JAKi in Tuscany: The LEONARDO study 177
Longitudinal adherence trajectories to biologic disease modifying anti-rheumatic drugs in Tuscany, Italy 174
Efficacy and safety of infliximab or adalimumab in severe mucocutaneous Behçet’s syndrome refractory to traditional immunosuppressants: a 6-month, multicentre, randomised controlled, prospective, parallel group, single-blind trial 159
Validation test for algorithms to identify rheumatoid arthritis patients in the Tuscan healthcare administrative databases 158
Utilisation patterns and clinical impact of the introduction of infliximab-biosimilar in Tuscany, Italy: real world evidence following the recommendation of switching for non-medical reasons 156
A case-matched cost-analysis of robot-assisted versus open pancreatoduodenectomy: Can the higher costs of advanced technology be offset by clinical advantages? 156
Robot-assisted pancreatoduodenectomy with the da Vinci Xi: can the costs of advanced technology be offset by clinical advantages? A case-matched cost analysis versus open approach 149
TABLET TOSCANA to Develop Innovative Organizational Models for Tele-Rehabilitation in Subjects with Congenital and Acquired Developmental Disabilities: A Wait-List Control Group Trial Protocol 141
RESEZIONI PANCREATICHE NEGLI ANZIANI: NE VALE LA PENA?. 139
Duration of response after DEB-TACE compared to lipiodol-TACE in HCC-naïve patients: a propensity score matching analysis 135
Recommendations by the Tuscan Health Authority to Use Infliximab-Biosimilar in the Clinical Practice: Safety Impact 134
Trajectories of use of biologic disease modifying antirheumatic drugs in rheumatoid arthritis: A cohort study of Tuscan patients, Italy 132
Utilization patterns and healthcare accesses of JAKi used in rheumatoid arthritis patients in Tuscany: The LEONARDO study 131
FIVE-YEAR EXPERIENCE OF ROBOTIC VS LAPAROSCOPIC RECTAL CANCER SURGERY IN A SINGLE CENTER: SURGICAL PARAMETERS AND COSTS ASSESSING ROBOTIC LEARNING CURVE 128
THE ECONOMIC IMPACT OF THE INTRODUCTION OF INFLIXIMAB-BIOSIMILAR: AN EMPIRICAL ANALYSIS USING THE TUSCANY HEALTHCARE ADMINISTRATIVE DATABASES 125
Structured cost analysis of robotic TME resection for rectal cancer: a comparison between the da Vinci Si and Xi in a single surgeon’s experience 123
RESEZIONI PANCREATICHE IN PAZIENTI OVER 70 119
Sleep quality mediates the effect of chronotype on resilience in the time of COVID-19 119
How Italy Tweeted about COVID-19: Detecting Reactions to the Pandemic from Social Media 118
COST-OPPORTUNITY OF PANCREATIC RESECTIONS IN ELDERLY 117
The Economic Impact of the Introduction of Infliximab-Biosimilar: Preliminary Results from a Study on Rheumatologic Patients in Tuscany, Italy 117
The calculation of the cardiac troponin T 99th percentile of the reference population is affected by age, gender, and population selection: A multicenter study in Italy 116
Evaluation of drug-utilization and healthcare facilities use in patients with ulcerative colitis and treated with biologic therapy using data of an Italian healthcare administrative database: Results from michelangelo study 114
Changes in the consumption in fruits and vegetables among university students during master courses: an analysis of data collected from cashier transaction 114
Robot-assisted rehabilitation for children with neurological disabilities: Results of the Italian consensus conference CICERONE 112
null 108
A Model-Based Analysis on Direct Costs of Adverse Drug Events and Related Cost-Savings Achievable by their Prevention in Tuscany, Italy 104
Switching from infliximab-originator to infliximab-biosimilar in rheumatologic patients: The clinical impact in Tuscan Region, Italy 100
null 99
Drug-Utilization, Healthcare Facilities Accesses and Costs of the First Generation of JAK Inhibitors in Rheumatoid Arthritis 95
Cost-Effectiveness of Treatment Optimisation with Biomarkers for Immunotherapy in Solid Tumours: A Systematic Review 92
The Economic Impact of Post-Traumatic Stress Disorder Among Patients with Systemic Autoimmune Diseases During the COVID-19 Pandemic 90
Assessment of Healthcare Facilities Associated with JAKi Drugs Used in Rheumatoid Arthritis Patients in Tuscany, Italy: The LEONARDO 85
Oral Presentation: Accesses to Emergency Department and Hospitalizations in New Users of Biologic Therapies for Ulcerative Colitis in Tuscany: The MICHELANGELO Study 77
Circadian typology and cognitive flexibility 70
Correction to: RarERN Path: a methodology towards the optimisation of patients’ care pathways in rare and complex diseases developed within the European Reference Networks (Orphanet Journal of Rare Diseases, (2020), 15, 1, (347), 10.1186/s13023-020-01631-1) 49
RarERN Path: a methodology towards the optimisation of patients’ care pathways in rare and complex diseases developed within the European Reference Networks 46
Rehabilitation with and without Robot and Allied Digital Technologies (RADTs) in stroke patients: a study protocol for a multicentre Randomised Controlled Trial on the effectiveness, acceptability, usability, and economic-organizational sustainability of RADTs from subacute to chronic phase (STROKEFIT4) 23
Totale 4.765
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.081
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.081
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202138 0 0 0 0 0 0 0 0 0 0 3 35
2021/2022347 8 15 45 44 49 41 12 15 14 10 25 69
2022/2023561 57 92 53 39 56 51 14 21 119 1 55 3
2023/2024357 10 22 31 9 39 59 54 26 4 6 40 57
2024/20251.322 16 38 47 91 81 167 77 54 105 199 154 293
2025/20261.684 147 202 230 156 202 113 284 58 129 154 9 0
Totale 4.765